首页> 美国政府科技报告 >Provisional Data Report on Malaria Surveillance and Use of Antimalarial Chemoprophylaxis, January-December 2003
【24h】

Provisional Data Report on Malaria Surveillance and Use of Antimalarial Chemoprophylaxis, January-December 2003

机译:2003年1月至12月关于疟疾监测和使用抗疟疾药物预防的临时数据报告

获取原文

摘要

Malaria is caused by infection with any of four species of the protozoan parasite Plasmodium (i.e., P. falciparum, P. vivax, P. ovale, P. malariae). The Plasmodium parasite is transmitted by the bite of an infected anopheline mosquito. Until the 1940s, malaria was endemic in the United States. Since then, malaria case surveillance has been conducted by CDC to monitor malaria infections and patient characteristics and risk factors, to detect locally acquired cases, and to monitor patterns of antimalarial chemoprophylaxis failures among U.S. travelers. The Malaria Branch at the Centers for Disease Control and Prevention (CDC) makes recommendations for chemoprophylaxis use for U.S. residents traveling to malarious areas. CDC currently recommends chloroquine as the antimalarial drug of choice for those persons visiting malarious areas that do not have reported strains of chloroquine-resistant P. falciparum.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号